Company intelligence / Profile preview

Oxford Drug Design

Oxford, England, United Kingdomoxforddrugdesign.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Oxford Drug Design has validated a novel first-in-class therapeutic mechanism in oncology targeting leucyl-tRNA synthetase. Their lead candidates have shown clear efficacy and dose response in mouse models. The company leverages a proprietary AI-driven platform for rapid identification of new chemical scaffolds with broad activity against cancer and resistant bacteria. No clinical trial results reported yet as all programs remain preclinical or IND-enabling.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Small moleculesDigital/AI-enabled drug design
Industry: Biotech

Partnerships

CARB-X (antibiotic R&D funding partnership)Innovate UK (grant support)academic collaborations with University of Oxford and others implied by team composition and advisory board appointments

Beyond the preview

Go deeper on Oxford Drug Design.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Drug Design.

Explore the full profile